|
RELATED PARTY TRANSACTIONS
|
3 Months Ended |
|---|---|
|
Mar. 31, 2013
|
|
| Related Party Transactions [Abstract] | |
| Related Party Transactions Disclosure [Text Block] |
8. RELATED PARTY TRANSACTIONS
Jamey Weichert, the Company’s Chief Scientific Officer and principal founder of Cellectar, and a director and shareholder of the Company, is a faculty member at the University of Wisconsin-Madison (“UW”). During the three months ended March 31, 2013, the Company made contributions to UW totaling $62,500 for use towards unrestricted research activities. No payments were made to UW for costs associated with clinical trial and other research agreements during the three months ended March 31, 2013. The Company made contributions to UW of $81,500 for use towards unrestricted research activities and paid UW $92,754 for costs associated with clinical trial agreements during the three months ended March 31, 2012. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|